October 28, 2011
SWHR convened an interdisciplinary roundtable of experts from academia, clinical medicine, industry, and the government to discuss the state-of-the-science in sex and gender differences in Alzheimer’s disease. Roundtable participants were asked to address gaps in our knowledge and identify specific sex-based research questions for future areas of study. The goal was to describe what is known about Alzheimer’s disease from a translational research perspective, with a focus on where the burden of disease falls, what sex differences have been found, and what crucial scientific questions remain to be answered.
The group was charged with answering the following questions:
- What are the key developments in your field?
- What are the gaps in knowledge?
- How can studying sex/gender differences help to fill these gaps?
Moderator: Chris Carter, PhD, MPH
- Skip Binder, PhD, Northwestern University
- David Biondi, DO, Janssen Scientific Affairs, LLC
- Roberta Diaz Brinton, PhD, University of Southern California
- Karen Duff, PhD, Columbia University
- Sam Gandy, MD, PhD, Mount Sinai
- Victor Henderson, MD, MS, Stanford University
- Pauline Maki, PhD, University of Illinois, Chicago
- David Michelson, MD, Merck & Co., Inc.
- Mary Mittelman, DrPH, New York University
- Darby Morhardt, MSW, LCSW, Northwestern University
- John Morrison, PhD, Mount Sinai
- Walter Rocca, MD, MPH, Mayo Clinic
- Rachel Schindler, MD, Pfizer, Inc.
- Steven Snyder, PhD, NIMH, NIH
- Rudy Tanzi, PhD, Harvard University
- Bill Thies, PhD, Alzheimer’s Association
Read the Summary Report published in the Journal of Women’s Health : Sex and Gender Differences in Alzheimer’s Disease:Recommendations for Future Research
For more information, please contact email@example.com.